EMI (Encore Medical) Dividends per Share: $0.00 (TTM As of Dec. 2025)


What is Encore Medical Dividends per Share?

Encore Medical EMI Dividends per Share is $0.00 as of Dec. 2025.

Encore Medical's dividends per share for the three months ended in Dec. 2025 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00. Its Dividend Payout Ratio for the three months ended in Dec. 2025 was 0.00. As of today, Encore Medical's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Encore Medical  (AMEX:EMI) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Encore Medical's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0/ -0.038
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Dividends per Share Related Terms

Encore Medical Dividends per Share Historical Data

* Premium members only.

The historical data trend for Encore Medical's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical Dividends per Share Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
Dividends per Share
0.00 0.00 0.00

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Dividends per Share Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

EMI vs : Dividends per Share Comparison

For the Medical Instruments & Supplies subindustry, Encore Medical's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Encore Medical Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encore Medical's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Encore Medical's Dividend Yield % falls into.


Encore Medical Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of $0.00 mean?
Encore Medical (EMI) has a Dividends per Share of $0.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Encore Medical and its competitors.
Is Encore Medical's Dividends per Share too high?
Encore Medical's current Dividends per Share is $0.00.
How does Encore Medical's Dividends per Share compare to ?
Encore Medical's Dividends per Share of $0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Medical Devices & Instruments company?
A good Dividends per Share depends on the Medical Devices & Instruments industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Encore Medical and its competitors. Encore Medical's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current Dividends per Share of $0.00. The current Dividends per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Encore Medical (EMI), the current Dividends per Share is $0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).